| | | | | |
FATE Fate Therapeutics, Inc. | €2,2034 | -2,48% | €273,41M | €751,12K | |
| €36,3588 | +1,57% | €273,34M | €13,71K | |
MLP Maui Land & Pineapple Co. | €13,8933 | +0,81% | €273,24M | €8,72K | |
NMRA Neumora Therapeutics, Inc. Common Stock | €1,4186 | +8,22% | €273,23M | €1,724 | |
GALT Galectin Therapeutics Inc. | €3,0270 | +0,00% | €273,09M | €259,45K | |
NREF NexPoint Real Estate Finance, Inc. | €14,8160 | +1,12% | €273,07M | €24,60K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | €9,3225 | -0,09% | €272,81M | €3,36K | |
| €2,7683 | +0,00% | €272,60M | €4,312 | |
EFR Eaton Vance Senior Floating-Rate Fund | €9,1846 | +0,00% | €272,43M | €94,74K | |
SMTI Sanara MedTech Inc. Common Stock | €29,4510 | +0,44% | €272,17M | €254,20K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | €9,0897 | +0,07% | €271,91M | €12,69K | |
ALTO Alto Ingredients, Inc. Common Stock | €3,6480 | +0,24% | €271,59M | €155,23 | |
RNGT Range Capital Acquisition Corp II Class A Ordinary Shares | €8,7447 | -0,10% | €271,24M | €7,761 | |
AFB Alliance National Municipal Income Fund, Inc. | €9,4692 | -0,54% | €271,19M | €96,22K | |
SSP The E.W. Scripps Company | €2,8459 | +1,23% | €270,92M | €226,04K | |
